A survey of European and Canadian rheumatologists regarding the treatment of patients with ankylosing spondylitis and extra-articular manifestations

Clinical Rheumatology

Volumn 29, Issue 3, 2010, Pages 281-288

  Van Den Bosch, Filip ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Ankylosing spondylitis; Biologics; Extra articular manifestation; Inflammation; Spondyloarthritides

Indexed keywords

ANKYLOSING SPONDYLITIS; ARTHROPATHY; ARTICLE; CANADA; CLINICAL FEATURE; CONTROLLED STUDY; CROHN DISEASE; DISEASE ASSOCIATION; EUROPE; HEALTH SURVEY; HUMAN; PRIORITY JOURNAL; PSORIASIS; SYMPTOM; ULCERATIVE COLITIS; UVEITIS; CLINICAL PRACTICE; DISABILITY; FEMALE; HEALTH CARE SURVEY; MALE; PSORIATIC ARTHRITIS; RHEUMATOLOGY;

ANTIRHEUMATIC AGENT;

ANTIRHEUMATIC AGENTS; ARTHRITIS, PSORIATIC; CANADA; CROHN DISEASE; DISABILITY EVALUATION; EUROPE; FEMALE; HEALTH CARE SURVEYS; HUMANS; MALE; PHYSICIAN'S PRACTICE PATTERNS; RHEUMATOLOGY; SPONDYLITIS, ANKYLOSING; UVEITIS;

EID: 77950598570     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-009-1317-6     Document Type: Article

References (30)

1. J Braun X Baraliakos J Brandt, et al. 2005 Therapy of ankylosing spondylitis. Part II: biological therapies in the spondyloarthritides Scand J Rheumatol 34 178 190 10.1080/03009740510026599 1:CAS:528:DC%2BD2MXnsVCgsL0%3D 16134723 (Pubitemid 40978638)
2. B Vander Cruyssen C Ribbens A Boonen, et al. 2007 The epidemiology of ankylosing spondylitis and the commencement of anti-TNF therapy in daily rheumatology practice Ann Rheum Dis 66 1072 1077 10.1136/ard.2006.064543 17261531 (Pubitemid 47122322)
3. D McGonagle W Gibbon P O'Connor, et al. 1998 Characteristic magnetic resonance imaging entheseal changes of knee synovitis in spondylarthropathy Arthritis Rheum 41 694 700 10.1002/1529-0131(199804)41:4<694::AID-ART17>3. 0.CO;2-# 1:STN:280:DyaK1c3gvFynuw%3D%3D 9550479 (Pubitemid 28214988)
4. J Braun M Bollow U Eggens, et al. 1994 Use of dynamic magnetic resonance imaging with fast imaging in the detection of early and advanced sacroiliitis in spondyloarthropathy patients Arthritis Rheum 37 1039 1045 10.1002/art. 1780370709 1:STN:280:DyaK2c3ps1CmsA%3D%3D 8024613 (Pubitemid 24222095)
5. B Muche M Bollow RJ François, et al. 2003 Anatomic structures involved in early- and late-stage sacroiliitis in spondylarthritis: a detailed analysis by contrast-enhanced magnetic resonance imaging Arthritis Rheum 48 1374 1384 10.1002/art.10934 1:STN:280:DC%2BD3s3itlKgtA%3D%3D 12746910 (Pubitemid 36554536)
6. L Laloux MC Voisin J Allain, et al. 2001 Immunohistological study of entheses in spondyloarthropathies: comparison in rheumatoid arthritis and osteoarthritis Ann Rheum Dis 60 316 321 10.1136/ard.60.4.316 1:STN:280:DC%2BD3M3gslGqug%3D%3D 11247858 (Pubitemid 32242741)
7. J Braun M Bollow L Neure, et al. 1995 Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis Arthritis Rheum 38 499 505 10.1002/art.1780380407 1:STN:280:DyaK2M3jsVSlug%3D%3D 7718003
8. M Bollow T Fischer H Reisshauer, et al. 2000 Quantitative analyses of sacroiliac biopsies in spondyloarthropathies: T cells and macrophages predominate in early and active sacroiliitis-cellularity correlates with the degree of enhancement detected by magnetic resonance imaging Ann Rheum Dis 59 135 140 10.1136/ard.59.2.135 1:STN:280:DC%2BD3c7ivFCgsQ%3D%3D 10666170 (Pubitemid 30305612)
9. J Braun R Landewé KG Hermann ASSERT Study Group, et al. 2006 Major reduction in spinal inflammation in patients with ankylosing spondylitis after treatment with infliximab: results of a multicentre, randomized, double-blind, placebo-controlled, magnetic resonance imaging study Arthritis Rheum 54 1646 1652 10.1002/art.21790 1:CAS:528:DC%2BD28XlsFWjsrc%3D 16646033
10. J Braun J Sieper 2002 Building consensus on nomenclature and disease classification for ankylosing spondylitis: results and discussion of a questionnaire prepared for the International Workshop on New Treatment Strategies in Ankylosing Spondylitis, Berlin, Germany, 18-19 January 2002 Ann Rheum Dis 61 Suppl 3 iii61 iii67 12381512
11. D Van der Heijde B Dijkmans P Geusens Ankylosing Spondylitis Study for the Evaluation of Recombinant Infliximab Therapy Study Group, et al. 2005 Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT) Arthritis Rheum 52 582 591 10.1002/art.20852 15692973 (Pubitemid 40216323)
12. AMJ Chorus HS Miedema A Boonen, et al. 2003 Quality of life and work in patients with rheumatoid arthritis and ankylosing spondylitis of working age Ann Rheum Dis 62 1178 1184 10.1136/ard.2002.004861 1:STN:280:DC%2BD3srpsFGlsw%3D%3D 14644855 (Pubitemid 37500623)
13. A Ozgül F Peker MA Taskaynatan, et al. 2006 Effect of ankylosing spondylitis on health-related quality of life and different aspects of social life in young patients Clin Rheumatol 25 168 174 10.1007/s10067-005-1150-5 16091840 (Pubitemid 43372313)
14. A Zink J Listing C Klindworth German Collaborative Arthritis Centres, et al. 2001 The national database of the German collaborative arthritis centres: I. Structure, aims, and patients Ann Rheum Dis 60 199 203 10.1136/ard.60.3.199 1:STN:280:DC%2BD3M7lvVahsQ%3D%3D 11171678 (Pubitemid 32260599)
15. SM van der Linden HA Valkenburg A Cats 1984 Evaluation of the diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria Arthritis Rheum 27 361 368 10.1002/art.1780270401 6231933
16. W Mau H Zeidler R Mau, et al. 1988 Clinical features and prognosis of patients with possible ankylosing spondylitis: results of a 10-year follow-up J Rheumatol 14 1109 1114
17. M Rudwaleit D van der Heijde MA Khan, et al. 2004 How to diagnose axial spondyloarthritis early Ann Rheum Dis 63 535 543 10.1136/ard.2003.011247 1:STN:280:DC%2BD2c7osFSjtQ%3D%3D 15082484 (Pubitemid 38530197)
18. M Rudwaleit R Landewe D van der Heijde, et al. 2009 The development of assessment of spondyloarthritis international society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal Ann Rheum Dis 68 770 776 10.1136/ard.2009.108217 1:STN:280:DC%2BD1MzjvVyguw%3D%3D 19297345
19. M Rudwaleit D van der Heijde R Landewe, et al. 2009 The development of assessment of spondyloarthritis international society classification criteria for axial spondyloarthritis (part II): validation and final selection Ann Rheum Dis 68 777 783 10.1136/ard.2009.108233 1:STN:280:DC%2BD1MzjvVygug%3D%3D 19297344
20. C Ribbens N Vastesaeger J Brasseur, et al. 2006 An epidemiological cross-sectional study of ankylosing spondylitis in Belgium: the ASPECT cohort Ann Rheum Dis 65 suppl II 539
21. J Zochling D van der Heijde R Burgos-Vargos, et al. 2006 ASAS/EULAR recommendations for the management of ankylosing spondylitis Ann Rheum Dis 65 442 454 10.1136/ard.2005.041137 1:STN:280:DC%2BD287ktFGqsg%3D%3D 16126791
22. H Haibel HC Brandt IH Song, et al. 2007 No efficacy of subcutaneous methotrexate in active ankylosing spondylitis: a 16 week open label trial Ann Rheum Dis 66 4 421 10.1136/ard.2006.054098 (Pubitemid 46579648)
23. R Van den Bosch E Kruithof M De Vos, et al. 2000 Crohn's disease associated with spondyloarthropathy: effect of TNF-α blockade with infliximab on articular symptoms Lancet 356 1821 1822 10.1016/S0140-6736(00) 03239-6 11117919
24. S Generini R Giacomelli R Fedi, et al. 2004 Infliximab in spondyloarthropathy associated with Crohn's disease: an open study on the efficacy of inducing and maintaining remission of musculoskeletal and gut manifestations Ann Rheum Dis 63 1664 1669 10.1136/ard.2003.012450 1:CAS:528:DC%2BD2cXhtFaktbjF 15297279 (Pubitemid 39573700)
25. Humira® (Adalimumab) Summary of Product Characteristics (SPC). February 2008
26. HUMIRA® (adalimumab) Receives FDA approval for treatment of Crohn's disease [press release]. Abbott Laboratories; February 27, 2007. Available via http://www.abbott.com/global/url/pressRelease/en-US/60.5:5/Press-Release-0428. htm. Accessed 4 Sept 2008
27. H Marzo-Ortega D McGonagle P O'Connor, et al. 2003 Efficacy of etanercept for treatment of Crohn's related spondyloarthritis but not colitis Ann Rheum Dis 62 74 76 10.1136/ard.62.1.74 1:STN:280:DC%2BD38jhsl2ruw%3D%3D 12480676 (Pubitemid 36005801)
28. Enbrel® (Etanercept) Summary of Product Characteristics (SPC). July 2008
29. Remicade® (Infliximab) Summary of Product Characteristics (SPC). August 2008
30. S Guignard L Gossec A Ruyssen-Witrand, et al. 2006 Tumor necrosis factor antibodies reduce uveitis flares more than soluble tumor necrosis factor receptor in spondyloarthropathy patients Ann Rheum Dis 65 suppl II 218